Osteo-Nutrients (with Vitamin K2-7)
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 50% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
2 Capsule(s)
Serving Size
60
Servings
Botanical with Nutrients
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
10 mcg
(50% DV)
✅ Within RDA (0.7× RDA of 0.015 mg)
📚 604 studies (Tier A: 16, B: 251)
25 mcg
(21% DV)
✅ Within RDA (0.2× RDA of 0.12 mg)
📚 273 studies (Tier A: 9, B: 175)
Calcium
600 mg
(46% DV)
200 mg
(48% DV)
📊 Market median: 4002.0mg (1 products)
📚 20 studies (Tier A: 0, B: 2)
50 mg
📊 Market median: 500.0mg (159 products)
Horsetail, Powder
50 mg
Other Ingredients
Cellulose
Magnesium Silicate
Ascorbyl Palmitate
Label Claims — Verification
❓
Nutrient
❓
All Other
❓
Structure/Function
All Other (100% of products)
Structure/Function (84% of products)
Nutrient (73% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Dairy Free
Sugar Free
Product Information
📋 Directions for Use
Recommendations Take 2-3 capsules 2-3 times daily with food, or as directed by your healthcare professional.
⚠️ Warnings & Precautions
Keep out of reach of children
Use only if safety seal is intact
Warning If you take Coumadin (warfarin) or other prescription blood thinners or are pregnant or nursing, consult your physician before taking.
🧪 Formulation Notes
Excludes coatings, binders, gluten (wheat, rye, barley), milk/dairy (casein, whey), soy protein, egg protein, sugar. Verified by independent testing
Albion Minerals
Raw materials and finished products are independently tested by U.S. labs.
Additional Information
Store sealed in a cool dry place
Learn more at vitalnutrients.net
Product Details
UPC / SKU
6 93465 31021 2
DSLD Entry Date
2024-06-20
Product Type
Botanical with Nutrients
Form
Capsule
Brand
Vital Nutrients
DSLD ID
305132
Data Updated
2026-04-11
Research Evidence
332
Research Sources
59
Avg Quality Score
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
A
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Compare Similar Products
Vitamin D Synergy with Vitamin K1
Designs for Health
100
Vitamin D Synergy with Vitamin K1
Designs for Health
100
Natural Vitamin K2 45 mcg
Doctor's Best
100
K 100 mcg
Thompson
100
Vitamin K2 300 mcg MK-7
Innerzyme
100